Subject to change.
Subject to change.
Keith supports Roche's digital pathology and oncology assays. He has worked in digital pathology since 2009, with experience in biopharma, diagnostics, and life sciences. Prior to that, he completed his MD and PhD in Molecular Biology from UCLA and pathology training at Stanford, and performed developmental biology research as a postdoc and lab head. He's passionate about next gen diagnostics combining multiplex labeling, digital pathology, and AI to realize the vision of personalized medicine.